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Abstract
Background The use of custom-made 3D-printed prostheses for reconstruction of severe bone defects in selected cases is
increasing. The aims of this study were to evaluate (1) the feasibility of surgical reconstruction with these prostheses in oncologic
and non-oncologic settings and (2) the functional results, complications, and outcomes at short-term follow-up.
Methods We analyzed 13 prospectively collected patients treated between June 2016 and January 2018. Diagnoses were primary
bone tumour (7 patients), metastasis (3 patients), and revision of total hip arthroplasty (3 patients). Pelvis was the most frequent
site of reconstruction (7 cases). Functional results were assessed with MSTS score and complications according to Henderson
et al. Statistical analysis was performed using Kaplan-Meier and log-rank test curves.
Results At a mean follow-up of 13.7 months (range, 6–26 months), all patients except one were alive. Oncologic outcomes show
seven patients NED (no evidence of disease), one NED after treatment of metastasis, one patient died of disease, and another one
was alive with disease. Overall survival was 100% and 80% at one and two years, respectively. Seven complications occurred in
five patients (38.5%). Survival to all complications was 62% at two years of follow-up. Functional outcome was good or
excellent in all cases with a mean score of 80.3%.
Conclusion 3D-printed custom-made prostheses represent a promising reconstructive technique inmusculoskeletal oncology and
challenging revision surgery. Preliminary results were satisfactory. Further studies are needed to evaluate prosthetic design,
fixation methods, and stability of the implants at long-term.
Keywords Pelvic tumours . Computer-aided design . 3D-printed prosthesis . Reconstruction . Complications . Bone tumour .
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Introduction
In recent decades, thanks to the advances in chemotherapy,
radiological and surgical techniques, limb-salvage surgery
has been shown to be safe and effective for the manage-
ment of primary and secondary bone tumors. Different re-
constructive strategies may be used to replace bone defect
after tumour removal, but each has its own specific indica-
tions and contraindications [1–3]. Modular endoprostheses
are nowadays the most common method of reconstruction
after resection of the long bones in the extremities for their
availability, relative ease use, immediate fixation and long-
term stability, early weight bearing, relatively rapid resto-
ration of function, and acceptable cosmesis [3–5]. Modular
prosthetic implants have been used also for pelvic recon-
structions with acceptable results [6, 7]. With the advent of
computer-aided design techniques and the improvement of
3D printing technology, in the last years, there is the pos-
sibility to reconstruct bone defects with personalized
custom-made prostheses [8, 9]. These types of implants
are specifically tailored for the defect and produced by
electron beam melting (EBM) technology that allows the
integration of the porous structure of the implant with the
host bone [10–12]. The expectation at long-term follow-up
is the reduction of mechanical complications, such as loos-
ening and fracture/breakage compared to conventional
prosthetic or allograft reconstructions [4, 10].
The aims of this study were to evaluate (1) the feasibility of
surgical reconstruction with custom made 3D-printed
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prostheses in patients with oncologic and non-oncologic set-
tings and (2) the functional results, complications, and out-
comes at short-term follow-up.
Materials and methods
We analyzed patients treated with custom-made 3D-printed
prosthesis, prospectively collected at the Authors’ institution
from June 2016 to January 2018. The research has been per-
formed in accordance with the Declaration of Helsinki. All
patients or their relatives gave written informed consent to
be included in scientific studies at the admission to the hospi-
tal. As this analysis consists of anonymized clinical routine
data, Research Ethics Committee Approval was not necessary
in our Institution. For all patients, we reviewed data regarding
patient comorbidities, cancer type, disease duration, staging,
and prognosis. Moreover, the analysis includes pre-operative
history and course, imaging evaluation, surgical data, use of
adjuvant treatments, oncologic outcome, complications, and
their applied treatment.
Thirteen patients were included in the study: there were 3
males (23%) and 10 females (77%) with a mean age of
55.3 years (range, 10–77 years) at surgery. The demographic
and oncological data are summarized in Table 1. All patients
underwent pre-operative plain radiography, computerized to-
mography (CT), and magnetic resonance imaging (MRI) of
the affected bone segment. Moreover, a high-resolution CT
scan (thin layer 1 mm) was performed on every patient before
the surgical procedure, possibly after removal of all previous
implants in case of revision surgery. The acquired images in
DICOM format were transferred to the manufacturing compa-
ny, and an accurate 3D virtual image and project was created,
via software, for each patient. In order to increase the stability
of the reconstruction, screw holes and other tools for fixation
of the prosthesis were designed together with engineers. In
two cases of pelvic reconstruction, polyaxial screwswere used
on the back for connection with lumbar pedicle instrumenta-
tion. With the EBM technology, the previously designed tita-
nium prosthesis is printed by the sintering of titanium powder
and then adequately prepared before surgical implantation.
The custom-made 3D-printed prostheses are provided with
cutting guides and textured surfaces to improve their integra-
tion with bone and soft tissue. It took approximately three to
four weeks for the design and manufacture of each personal-
ized 3D-printed prosthesis. Three different implants were
used: Promade (Lima, San Daniele del Friuli, Udine, Italy),
Mt. Ortho (Catania, Italy), and C-Fit 3D® (Implantcast Ltd.,
Buxtehude, Germany).
Clinical data and surgical procedures Despite multiple sur-
geons contributing to patients’ management, the choice of
operative strategy was based on multidisciplinary evaluation
of our oncological team. The general indications for resection
and reconstruction with custom-made 3D-printed prosthesis
were (1) extensive bone loss and bone destruction that pre-
cluded the use of standard modular prostheses and (2) affect-
ing site where massive allografts were the only alternative
reconstructive method. Reasons for custom-made 3D-printed
prosthetic implant were reported in Table 2. In summary, in
three patients, it was used as revision implant after failure of
total hip replacement, and in ten patients with oncologic dis-
ease as primary implant after resection of bone tumour (7
cases) or as revision implant after failed previous replacement
(2 cases) or local recurrence (1 case). Revision surgery in
oncologic setting was performed in one patient using an inter-
calary custom prosthesis after breakage of femoral
intramedullary nail due to myeloma diaphyseal localization,
in another patient as revision of mobilized modular stemmed
acetabular cup and in a patient with recurrent giant cell tumor
(GCT) of the distal tibia after multiple intralesional treatments.
Anatomical sites of reconstruction were pelvis in seven cases
and scapula, ulnar diaphysis, distal radius, calcaneus, distal
tibia, and femoral diaphysis in one case each. Stem fixation
Table 1 Demographic and oncological data of patients reconstructed
with custom-made 3D-printed prostheses (n = 13)
Data Patients %
Age and gender
Age (mean years) 55.3 (range, 10–77)
Gender (male/female) 3/10
Pathological diagnosis
Chondrosarcoma 3 23.1
Metastatic carcinoma 3 23.1
Osteosarcoma 2 15.3
Ewing’s sarcoma 1 7.7
Recurrent giant cell tumor 1 7.7
Non-oncological cases
Loosening in total hip arthroplasty 2 15.3
Pseudotumor in total hip arthroplasty 1 7.7
Type of implant
Primary reconstruction 7 53.8
Revision of previous failed implants 6 46.2
Site
Pelvis 7 53.8
Scapula, ulnar diaphysis, distal radius,
calcaneus, distal tibia, and femoral
diaphysis in one case each
6 46.2
Surgical margins in oncologic patients Wide 10/10 100.0
Adjuvant treatments
Chemotherapy 3 23.1
Chemo + radiation therapy 3 23.1
Denosumab 1 7.7
None 6 46.1
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was cemented in older patients with bone metastases and
low bone stock (3 cases), while press-fit in younger patients
and patients with primary bone tumours (10 cases).
Histological diagnoses in ten patients with oncologic dis-
ease included chondrosarcoma in three (23%) patients,
metastatic carcinoma in three (23%), osteosarcoma in two
(15.3%), Ewing’s sarcoma and giant cell tumour in one
each. According to the surgical staging system for muscu-
loskeletal tumors, one benign tumour was classified as
stage 3 and malignant tumours were classified as stage IIb
(n = 6) and stage IIIb (n = 3). Adjuvant treatments were ad-
ministered according to the primary cancer. Chemotherapy
was performed in six patients with osteosarcoma, Ewing’s
sarcoma, and metastatic lesion, whereas three of these re-
ceived external beam radiotherapy also. The patient treated
for recurrent GCT had pre-operative treatment with
denosumab.
Post-operative assessments All patients were followed by
the rehabilitation center at our institution. Post-operative
immobilization was obtained with pelvic-thigh brace in
all cases of pelvic reconstruction: brace was positioned at
10° of abduction and fixed in extension for 1 month, then
with flexion up to 90° for another month. Weight bearing
was allowed after one week in case of cemented stem and
after one month in case of press-fit stem. Immobilization
for a month was obtained with brace at 15° of abduction
after shoulder reconstruction, with Velpeau-brace after ul-
nar reconstruction, with Walker-brace after distal tibia re-
construction and with wrist-brace after distal radio recon-
struction. Anti-thrombotic stockings and calf compression
Table 2 Patient characteristics
and indications for custom-made
3D-printed prosthetic implant
N. pt Age,
gender
Site Diagnosis and reasons for custom-implant Implant
manufacturer
1 (G.V.) 77, F Pelvis Non-oncologic acetabular-femoral reconstruction
in failed total hip revision prosthesis
Lima ®
2 (A.G.) 79, F Pelvis Non-oncologic acetabular-femoral reconstruction
in failed total hip revision prosthesis
Lima®
3 (M.P.) 78, F Pelvis Non-oncologic setting. Excision of large
pseudotumor in metal-metal total hip
replacement
Lima®
4 (M.A.) 56, M Pelvis Primary implant in grade 2 chondrosarcoma
treated with type II pelvic resection
Implantcast®
5 (G.G.) 51, F Pelvis Revision surgery in oncologic patient: breast
cancer metastasis of the periacetabular-area
treated with type II pelvic resection and
stemmed modular megaprosthesis complicated
by implant loosening and hip dislocation
Implantcast®
6 (R.C.) 26, F Pelvis Primary implant in stage III osteosarcoma of the
iliac wing treated with type I pelvic resection
and reconstructed with 3D-printed custom
prosthesis and spinopelvic fixation
MtOrtho®
7 (V.M.) 53, F Pelvis Primary implant in Ewing’s sarcoma treated with
type I–II pelvic resection reconstructed with
3D-printed custom prosthesis and spinopelvic
fixation
Implantcast®
8 (M.P.) 63, M Scapula Primary implant in clear cell chondrosarcoma
treated with partial scapulectomy reconstructed
with 3D-printed custom prosthesis and inverse
proximal humerus prosthesis
Lima®
9 (G. F.) 74, M Ulna Primary implant in intercalary resection of
metastatic lesion (unknown origin) in diaphyseal
ulna
MtOrtho®
10 (E.B.) 11, F Radius Primary implant in high grade osteosarcoma of the
distal radius
MtOrtho®
11 (AM.C.) 72, F Femur Revision surgery in oncologic patient: breakage of
intramedullary nail as treatment of myeloma
affecting femur diaphysis
MtOrtho®
12 (E.V.) 27, F Tibia Revision surgery in oncologic patient: recurrent
giant cell tumor of the distal tibia in previous
intralesional surgeries and cement
Implantcast®
13 (G.D.) 60, F Calcaneus Primary implant in grade 1 chondrosarcoma of the
calcaneus
MtOrtho®
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devices were routinely used for prophylaxis against deep
vein thrombosis after lower limb or pelvic reconstruction.
Routine follow-up examinations were performed with am-
bulatory checks every three months during the first three
years after surgery, then every four months in the fourth
years, then every six months for one year, and then annu-
ally. Follow-up evaluations included physical examination,
radiographs, and disease-specific chest imaging. No pa-
tient was lost to follow-up. Oncologic results were evalu-
ated according to local recurrence, metastasis, or death,
and patients were classified as follows: (1) no evidence
of disease at the latest routine check (NED); (2) disease
free after treatment of local recurrence or metastasis
(NEDrl or NEDm); (3) alive with disease, due to presence
of local recurrence or metastasis (AWD); and (4) dead of
disease (DWD). Survival was defined as the time from
surgery to last follow-up or death. Complications were
classified according to Henderson et al. [13] in type I (soft
tissue failure), type II (aseptic loosening), type III (break-
age), type IV (infection), and type V (local recurrence).
Moreover, complications were considered as intra-opera-
tive, early (within 6 months post-operatively), and late
(more than 6 months post-operatively). Functional results
were assessed for all surviving patients using the
Musculoskeletal Tumor Society (MSTS) functional rating
system.
Statistical analysis The categorical variables were
expressed as percentages. Survival was analyzed using
the Kaplan-Meier analysis. Comparison of the curves
was done with the log-rank test. Differences were con-
sidered statistically significant when the p value was
less than 0.05. The data were recorded in a Microsoft1
Excel1 2003 spreadsheet and analyzed using Med-Calc
Software Version 11.1 (MedCalc Software, Mariakerke,
Belgium).
Results
Operational outcomes En-bloc resection was achieved in all
patients with wide surgical margins. One patient had an oste-
osarcoma with suspicious tumour localization in the fifth lum-
bar vertebra; therefore, resection was extended and cement
was used to fill the space between custom-prosthesis and host
bone at the time of surgery. Two patients with oncologic pel-
vic reconstruction were stabilized with spino-pelvic instru-
mentation, whereas in the other two cases, iliac and sacral
screws were used. No patient died of intra/perioperative
complications.
Oncologic outcomes At a mean follow-up of 13.7 months
(range, 6–26 months), patients with oncologic disease were
NED in seven cases, AWD in one case, NEDm in one case,
and DWD in one case. One patient with distal radius osteo-
sarcoma is without evidence of disease after surgical treatment
of lung metastasis, one patient with stage IIb pelvic osteosar-
coma died 15 months after surgery due to rapid tumour pro-
gression with bone and visceral metastases, while one patient
with breast cancer metastasis is still alive with disease and she
is under chemotherapy for other bone metastases. Overall sur-
vival was 100% and 80%, respectively, at 12 and 24 months
(Fig. 1).
Fig. 1 A Kaplan-Meier survival
curve shows the overall survival
of the entire population. Survival
was 100% and 80% at 1 and
2 years, respectively
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Complications Complications occurred in 38.5% of cases (7
complications in 5/13 patients), at a mean time of 2.7 months
(range, 0.3–12 months). Survival of the entire series to all
complications was 62% at one year follow-up (Fig. 2a),
whereas it was 72% considering major complications only
(Fig. 2b). Type I complications occurred in four cases as
post-operative (less than 1 month after surgery) wound dehis-
cence. Wound dehiscence was successfully treated with surgi-
cal wound debridement, antibiotic therapy per os, and VAC
therapy in one patient (case no. 1 Table 2) with custom pros-
thesis as revision of THA failure. The patient with reconstruc-
tion of the calcaneus (case no. 13 Table 2) was successfully
treated with surgical debridement and musculocutaneous flap
without implant removal. In the other cases (pelvic
reconstruction, case nos. 5 and 6 Table 2), wound dehiscence
was treated with surgical debridement and antibiotic therapy,
but successively, patients developed deep infection (type IV)
at a mean of four months (range, 1–12 months). One of these
was early diagnosed and then successfully treated with surgi-
cal debridement and musculocutaneous flap without implant
removal. The other one developed a late infection (12 months
after surgery) and was treated with surgical debridement, plas-
tic flap, and oral antibiotic drugs without prosthesis removal
due to poor general condition: in fact, the patient had multiple
Fig. 2 Kaplan-Meier survival
curves show a the overall survival
to complications that was 62% at
1 and 2 years, respectively, and b
the survival to major
complications (loosening,
breakage, infection) that was 85%
at 6 months and 72% after 1 year
of follow-up
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bone and visceral metastases and died three months later. We
observed a higher incidence of infections in patients treated
with pelvic reconstructions than other sites, even if without a
significant difference at univariate analysis (p = 0.2667). Type
II and type V complications never occurred, while type III
complication was reported in one case (case no. 11). Patient
treated with intercalary femur reconstruction had a
periprosthetic fracture due to fall 45 days after surgery and
was revised with a less invasive stabilization system (LISS)
plate and bone allograft.
Functional results After surgery, all patients experienced im-
provement in quality of life resulting from reduction or resolv-
ing of pain. The recovery of the affected limb function was
assessed according to the MSTS score in all alive patients at
the final follow-up. The mean MSTS score was 80.3%, with
good (between 51 and 75%) or excellent (between 76 and
100%) in all patients. Analyzing separately the functional re-
sults, we observed a mean MSTS score of 64.5% (range, 57–
70%) in patients treated of complex revision surgery in non-
oncologic settings, 74% (range, 73–76%) in reconstructions
after resection of pelvic bone tumours, and 88% (range, 80–
93%) in patients with reconstruction of sites other than pelvis,
with a statistically significant difference (p = 0.010) (Fig. 3).
Discussion
The introduction of 3D printing technology increased the ar-
mamentarium of the orthopaedic surgeon in approaching large
bone defects in complex revision surgery and musculoskeletal
oncology. This technology may realize customizable patient-
specific implants that could be used as alternative to massive
bone allografts or in other sites where modular prosthesis are
not available [10, 14]. The advantages include (1) the possi-
bility to produce implants with complex shapes with a porous
structure; the porous scaffold allows the growth of host bone
inside the implant to achieve a stable reconstruction; (2) the
increased accuracy of skeletal reconstruction reducing the risk
of miss-match between allografts/adapted prostheses to host
bone; (3) immediate stability with production of titanium
prostheses that has sufficient mechanical strength to bear the
body weight or allow full function of the body segment; and
(4) the full availability than the allograft or other systems in
most institutions [10, 14–17]. We present the preliminary re-
sults of our series of 13 patients treated with custom-designed
3D-printed prostheses in different oncologic and non-
oncologic settings. These prostheses have been used for dif-
ferent types of demanding bone defects, showing satisfactory
results in terms of surgical technique, operating time, safety,
and functional outcomes. The complication rate is comparable
to that of other complex reconstructions based on skeletal site.
Our study has some limitations. (1) There was heterogene-
ity of the patient population, and indications for all patients
were either oncologic or revision; therefore, surgical expo-
sures were not standardized and were dictated by the tumor
location or pre-existing incisions. (2) Although this study is
one of the largest series of custom-made 3D-printed prosthe-
ses, it has only 13 patients with adequate follow-up and het-
erogeneous surgical indications, thereby limiting the power of
the series to show potentially statistically significant trends.
On the other hand, this study provides interesting data and
information for this new reconstructive technique. Moreover,
considering the difficulty of analyzing large homogeneous
series, a power analysis to determine how many patients in
each group should be included to show a difference was not
Fig. 3 Graphic visualization of
functional results at MSTS score.
Patients were divided in three
groups based on site of
reconstruction and oncologic
setting, showing significant lower
results in those with pelvic
reconstruction (p = 0.010). Dots
represent the last MSTS score of
each patient, whereas horizontal
lines represent the mean MSTS
score of the group. One patient
who died of disease was excluded
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performed. (3) Heterogeneity and small sample size should be
considered in the analysis of possible confounding variables.
(4) The relatively short follow-up period of this study does not
account for late complications that may arise as we follow
these patients for a longer time. However, all the patients were
prospectively analyzed and collected, reducing the risk of er-
roneous data or lost to follow-up. Larger multicentric studies
should be realized for better evaluation of surgical indications,
with comparison of different experienced centres at long-term
follow-up.
The treatment of extensive acetabular bone loss and pelvic
discontinuity is challenging in some cases of complex revi-
sions. None of the commonly used reconstructive techniques
has been able to provide optimal results in case of Paprosky
3A and 3B bone defects [18, 19]. In the recent years, several
Authors have therefore begun to use custom-made 3D-printed
prostheses in non-oncologic settings, with encouraging results
[15, 20–22]. Some Authors reported encouraging results with
custom 3D-printed tri-flanged acetabular implants for the
management of severe acetabular defects: Taunton et al. ret-
rospectively analyzed 57 patients with pelvic discontinuity
reporting a stable implant at a mean follow-up of 65 months,
despite high incidence of complications [21]. A significant
improvement in functional scores and radiographic outcomes
has been reported in other series of patients treated with
custom-made 3D-printed pelvic reconstructions, with a com-
plication rate ranging from 12.5 to 33.3% [23–26]. In our
series, we reported similar results in three female patients
(nos. 1, 2, and 3) with a mean age of 75 years (range, 68–
79 years) treated for failed revised total hip arthroplasty. At a
mean follow-up of 18 months (range, 8–24 months), only one
complication (wound dehiscence) was observed and has been
surgically treated without removal of the implant. At the last
follow-up, all patients presented no sign of loosening at radio-
graphs and the mean MSTS score was 64.5% (range, 57–
70%). Considering the good results obtained in revision sur-
gery of the pelvis, the use of 3D simulation and printing tech-
niques have been recently extended in other fields of orthope-
dics, such as treatment of complex pelvic fractures [27, 28] or
surgical planning and correction of technically challenging
bone deformities [29, 30].
Concerning pelvic tumours, in the past, most of these cases
were considered inoperable or the common method of man-
aging was external hemipelvectomy [31]. Currently, with ad-
vances in radio/chemotherapy and surgical techniques, limb-
salvage surgery has become an accepted treatment [22–36].
Various biological and prosthetic methods have been used for
pelvic reconstruction after tumor resection including arthrod-
esis, hip transposition, massive allograft/autograft, and differ-
ent designed prosthetic implants [33, 34, 36]. However, the
optimal reconstruction method remains controversial, espe-
cially in periacetabular area. Biological reconstruction has
the theoretical potential of a permanent consolidation with
host bone, even if the high rate of deep infection (range 15–
55%) and mechanical failures (range 9–22%) significantly
reduced their use in recent years [34, 37–39]. Prosthetic re-
construction has the advantages of allowing early mobiliza-
tion, immediate and long-term stability with satisfactory cos-
metic, and functional results [9, 35, 40, 41]. The advent of 3D
printing technology may combine the benefits of both tech-
niques, and recently, there has been a great increase in the use
in oncologic settings [8, 9, 14, 41]. In 2002, Ozaki et al. [41]
reported an experience with computer-aided custom-made
Vitallium prostheses for pelvic reconstruction. In this early
report, the Authors observed a high complication rate and
poor functional results after hemipelvic resection and pros-
thetic reconstruction. Dai et al. [9] reported in 2007 their ex-
perience in using custom-made 3D-printed prostheses after
pelvic resection. They analyzed ten patients treated for bone
tumours involving the acetabular area at a mean age of
48 years. Despite the rate of complications remaining high
compared to previous reports, functional results were good
in more than 70% of the cases at a mean of 34-month fol-
low-up [9]. Wang et al. [42] recently reported their experience
in 11 treated for malignant tumours (localized sarcoma or
solitary metastasis) in the periacetabular region. They used a
3D-printed prosthesis that precisely matched the residual part
of the iliac crest, sacroiliac joint, or sacrum (fixed with can-
cellous and locking screws) and the pubis, searching a com-
plete restoration of the pelvic ring. Liang et al. [14] reported
the largest series of patients (35 cases) treated reconstructed
with custom-made 3D-printed prostheses after pelvic resec-
tion for bone tumours. Types of pelvic resections were the
following: type I in three cases, type II + III in 12 cases, type
I + II in five cases, type I + II + III in two cases, type I + II + IV
in ten cases, and type I + II + III + IV in 3 cases. They used
three different prosthetic concepts. A 3D-printed iliac prosthe-
sis of adequate size fixed with sacral, ischium, and pubic
screws was used in type I resections to restore the continuity
of the pelvic ring. A 3D-printed hemipelvic prosthesis of suit-
able size, augmented with bone cement and conventional total
hip arthroplasty, was used for resections including acetabular
area. The fixation was obtained with perfect fit to the contour
of residual ilium, long sacral cancellous screws, and two or
more cortical screws. A 3D-printed prosthesis with screw-rod
connection has been used for larger reconstructions of the
entire hemipelvis [14]. In our experience, we adopt a slightly
different protocol to decide the type of pelvic reconstruction
after bone tumor resection, primarily based on the proximal
resection level of the ilium (Fig. 4). In pelvic resections in-
volving the entire iliac bone or part of the sacrum, we prefer a
reconstructionwith a custom-made 3D-printed prosthesis with
spinopelvic stabilization (Fig. 5a). The same choice when the
residual part of the ilium is not adequate and sufficient to
accommodate a modular stemmed acetabular cup (Fig. 5b).
In type I–II resections with a good support of the iliac bone,
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Fig. 4 Decision-making
algorithm for the choice of
reconstructive technique after
pelvic resection for bone tumors
based on our experience
Fig. 5 Explicative cases of pelvic reconstruction based on our decision-
making algorithm. a Twenty-six-year-old female, with stage III osteosar-
coma of the iliac wing treated with type I pelvic resection and reconstruc-
tion with 3D-printed custom prosthesis and spinopelvic fixation (case no.
6 of the present series). b Fifty-three-year-old female, with Ewing’s sar-
coma of the pelvis treated with type I–II pelvic resection and reconstruc-
tion with 3D-printed custom prosthesis and spinopelvic fixation (case no.
7 of the present series). c Seventy-two-year-old male, with peripheral
chondrosarcoma of the acetabular area treated with type II pelvic resec-
tion and reconstruction using modular prosthesis with stemmed acetabu-
lar cup. d Fifty-eight-year-old male, with grade 2 chondrosarcoma of the
acetabulum treated with type II resection and ileo-femoral coarctation
considering the limited shortening expected and good muscle
preservation
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we prefer a modular prosthesis with stemmed acetabular cup
(Fig. 5c). A coarctation is used in specific cases such as young
patients with limited muscle removal and limited shortening
expected or old patients with poor general conditions (Fig.
5d).
Other field of application of custom-made 3D-printed pros-
theses includes the reconstruction after bone resection for tu-
mour in particular skeletal segments in which there are no
available standard modular prostheses, as an alternative to mas-
sive allograft. In literature, there are described small series and
case reports reporting custom-made prosthetic reconstructions
of the scapula, clavicula, radius, vertebral body, and calcaneus
[16, 43–45]. In most of the cases, immediate stability and good
cosmetic appearance have been achieved with these anatomical
reconstructions, even if the follow-up is usually too short in
order to establish functional results and complication rate. In
our series, we have reported six cases of custom-made 3D-
printed prosthetic reconstructions of unusual sites (scapula, in-
tercalary ulna, distal radius, calcaneus, distal tibia, and interca-
lary femur). At a mean follow-up of 9.4 months (range 6–
17 months), two complications were observed: a periprosthetic
fracture after accidental traumatic fall and a wound dehiscence
which however did not require removal of the implant.
Functional results were satisfactory in all cases, with an average
MSTS score of 88% (range, 80–93%).
Conclusions
The use of 3D-printed titanium prostheses is growing in mus-
culoskeletal oncology and revision surgery. This technology
may be useful to obtain a complete restoration of the bone
defect and acceptable functional results, even if the complica-
tion rate remains high in difficult sites such as the pelvis. We
believe that custom-made 3D-printed prostheses represent to-
day a promising reconstructive technique, maintaining how-
ever the correct indications for their use in musculoskeletal
oncology and challenging revision surgery. Further studies
are needed to validate the more appropriate design of prosthe-
sis and its fixation to the host bone (especially in pelvic recon-
structions), in terms of stability at long-term follow-up.
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